Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC-15: Pediatric Oral Ivermectin in Scabies
NCT06404333Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in scabies, sponsored by University of Oxford. Started Feb 2025; status: completed.
02
Drugs
ivermectin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT06404333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06404333.